- Home
- WSBC vs HCM Comparison
WSBC vs HCM Comparison
Compare WSBC & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WSBC
- HCM
- Stock Information
- Founded
- WSBC 1870
- HCM 2000
- Country
- WSBC United States
- HCM Hong Kong
- Employees
- WSBC N/A
- HCM N/A
- Industry
- WSBC Major Banks
- HCM Biotechnology: Pharmaceutical Preparations
- Sector
- WSBC Finance
- HCM Health Care
- Exchange
- WSBC Nasdaq
- HCM Nasdaq
- Market Cap
- WSBC 2.1B
- HCM 2.3B
- IPO Year
- WSBC N/A
- HCM N/A
- Fundamental
- Price
- WSBC $35.22
- HCM $13.52
- Analyst Decision
- WSBC Buy
- HCM Hold
- Analyst Count
- WSBC 5
- HCM 1
- Target Price
- WSBC $39.40
- HCM $19.00
- AVG Volume (30 Days)
- WSBC 454.3K
- HCM 85.0K
- Earning Date
- WSBC 01-22-2025
- HCM 02-26-2025
- Dividend Yield
- WSBC 4.31%
- HCM N/A
- EPS Growth
- WSBC N/A
- HCM N/A
- EPS
- WSBC 2.26
- HCM N/A
- Revenue
- WSBC $586,985,000.00
- HCM $610,806,000.00
- Revenue This Year
- WSBC N/A
- HCM N/A
- Revenue Next Year
- WSBC $12.57
- HCM $18.76
- P/E Ratio
- WSBC $15.19
- HCM N/A
- Revenue Growth
- WSBC 0.50
- HCM N/A
- 52 Week Low
- WSBC $25.56
- HCM $13.00
- 52 Week High
- WSBC $37.36
- HCM $21.92
- Technical
- Relative Strength Index (RSI)
- WSBC 62.99
- HCM 40.71
- Support Level
- WSBC $33.91
- HCM $13.10
- Resistance Level
- WSBC $35.59
- HCM $13.92
- Average True Range (ATR)
- WSBC 1.04
- HCM 0.38
- MACD
- WSBC 0.34
- HCM 0.02
- Stochastic Oscillator
- WSBC 90.21
- HCM 37.96
About WSBC WesBanco Inc.
Wesbanco Inc is a bank holding company that offers a full range of financial services, including retail banking, corporate banking, personal and corporate trust services, brokerage services, mortgage banking, and insurance. The company has two reportable segments: community banking and trust and investment services. WesBanco operates one commercial bank, WesBanco Bank, which runs scores of branches. Its market service area primarily includes the Rust Belt region of the United States. Commercial real estate accounts for nearly half of the bank's loan portfolio. The bank has historically grown through both organic growth and acquisitions. The bank's primary component of net revenue is net interest income.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.